TJ189R3 - Inclusion complexes of 3-morpholinesydnonimine or its salts, or its tautomeric isomer with cyclodextrine or its deri-vatives, method for preparation thereof, pharmaceutical composition thereof, methodfor preparation thereof and for treatment of sten ocardia or ishemic desease. - Google Patents

Inclusion complexes of 3-morpholinesydnonimine or its salts, or its tautomeric isomer with cyclodextrine or its deri-vatives, method for preparation thereof, pharmaceutical composition thereof, methodfor preparation thereof and for treatment of sten ocardia or ishemic desease.

Info

Publication number
TJ189R3
TJ189R3 TJ94000008A TJ94000008A TJ189R3 TJ 189 R3 TJ189 R3 TJ 189R3 TJ 94000008 A TJ94000008 A TJ 94000008A TJ 94000008 A TJ94000008 A TJ 94000008A TJ 189 R3 TJ189 R3 TJ 189R3
Authority
TJ
Tajikistan
Prior art keywords
preparation
salts
morpholinesydnonimine
ocardia
ishemic
Prior art date
Application number
TJ94000008A
Inventor
Maria Vikmon
Jozsef Szejtli
Lajos Szente
Jozsef Gaal
Istvan Hermecz
Agnes Horvath
Katalin Marmarosi
Gabor Horvath
Iren Munkacsi
Original Assignee
Therabel Ind Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therabel Ind Sa filed Critical Therabel Ind Sa
Publication of TJ189R3 publication Critical patent/TJ189R3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/04—1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles

Abstract

PCT No. PCT/HU91/00013 Sec. 371 Date Jan. 2, 1992 Sec. 102(e) Date Jan. 2, 1992 PCT Filed Mar. 28, 1991.The invention relates to inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof and pharmaceutical compositions containing the same. The inclusion complex of 3-morpholino-sydnonimine or its salt formed with cyclodextrin derivative is prepared by a) reacting the 3-morpholino-sydnonimine or its salt in an aqueous medium with a cyclodextrin derivative and the complex is isolated from the solution by dehydratation, or b) high energy milling of 3-morpholino-sydnonimine or its salt and a cyclodextrin derivative.
TJ94000008A 1990-03-28 1994-11-28 Inclusion complexes of 3-morpholinesydnonimine or its salts, or its tautomeric isomer with cyclodextrine or its deri-vatives, method for preparation thereof, pharmaceutical composition thereof, methodfor preparation thereof and for treatment of sten ocardia or ishemic desease. TJ189R3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU901869A HU212730B (en) 1990-03-28 1990-03-28 Process for producing inclusion complexes of cyclodextrine or its derivative and 3-morpholino-sydnonimine or its salt or its tautomer and pharmaceutical compositions containing them
SU5010582A RU2107695C1 (en) 1990-03-28 1991-03-28 Inclusion complex of 3-morpholinosidnonimin or salt thereof or tautomeric isomer thereof with cyclodextrin or its derivative, method for its production and pharmaceutical composition containing it, method for producing pharmaceutical composition and method for treating stenocardia and heart's ischemic disease in humans
PCT/HU1991/000013 WO1991014681A1 (en) 1990-03-28 1991-03-28 Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same

Publications (1)

Publication Number Publication Date
TJ189R3 true TJ189R3 (en) 1998-10-28

Family

ID=10956597

Family Applications (1)

Application Number Title Priority Date Filing Date
TJ94000008A TJ189R3 (en) 1990-03-28 1994-11-28 Inclusion complexes of 3-morpholinesydnonimine or its salts, or its tautomeric isomer with cyclodextrine or its deri-vatives, method for preparation thereof, pharmaceutical composition thereof, methodfor preparation thereof and for treatment of sten ocardia or ishemic desease.

Country Status (33)

Country Link
US (1) US5298496A (en)
EP (1) EP0478732B1 (en)
JP (1) JP2549961B2 (en)
KR (1) KR950004706B1 (en)
CN (1) CN1051081C (en)
AT (1) ATE170849T1 (en)
AU (1) AU635835B2 (en)
BG (1) BG61812B1 (en)
BR (1) BR9105137A (en)
CA (1) CA2054213C (en)
CZ (1) CZ285695B6 (en)
DE (1) DE69130146T2 (en)
DK (1) DK0478732T3 (en)
ES (1) ES2121780T3 (en)
FI (1) FI104882B (en)
GE (1) GEP19991743B (en)
HK (1) HK1011688A1 (en)
HR (1) HRP920560B1 (en)
HU (2) HU211648A9 (en)
LT (1) LT3257B (en)
LV (1) LV10087B (en)
MC (1) MC2186A1 (en)
MD (1) MD776C2 (en)
MW (1) MW6891A1 (en)
NO (1) NO303634B1 (en)
OA (1) OA09522A (en)
PL (1) PL165866B1 (en)
RO (1) RO109336B1 (en)
RU (1) RU2107695C1 (en)
SI (1) SI9110909B (en)
TJ (1) TJ189R3 (en)
UA (1) UA27242C2 (en)
WO (1) WO1991014681A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU210921B (en) * 1990-03-28 1995-09-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine formed with cyclodextrines and pharmaceutical compositions containing them
DE4117249C2 (en) * 1991-05-27 1998-05-14 Christian Dr Stief Linsidomine used to treat erectile dysfunction
HU213200B (en) 1993-05-12 1997-03-28 Chinoin Gyogyszer Es Vegyeszet The cyclodextrin or cyclodextrin derivative cluster complexes of taxol, taxotere, or taxus, pharmaceutical preparations containing them and process for their production
HU218280B (en) * 1994-04-26 2000-07-28 Cyclodextrin inclusion complexes containing sin-1a which are stable intheir solid state, process for their preparation and pharmaceutical compositions containing the comlexes
GB9915231D0 (en) 1999-06-29 1999-09-01 Pfizer Ltd Pharmaceutical complex
FR2805462B1 (en) * 2000-02-24 2003-08-15 Therabel Res NEW ORAL GALENIC FORM WITH EXTENDED RELEASE OF MOLSIDOMINE
JP2003532757A (en) * 2000-05-11 2003-11-05 イーストマン ケミカル カンパニー Acylated cyclodextrin: guest molecule inclusion complex

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1496056A (en) * 1964-06-08 1967-09-29 Takeda Chemical Industries Ltd New chemical compounds of the sydnonimine type
DE3221425A1 (en) * 1982-06-07 1983-12-08 Boehringer Ingelheim KG, 6507 Ingelheim HYDROLYSIS-SENSITIVE ACTIVE SUBSTANCE CONTAINING STORAGE TABLET
DE3346638A1 (en) * 1983-12-23 1985-07-04 Cassella Ag, 6000 Frankfurt PHOTOSTABILIZATION OF MOLSIDOMIN
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
DE3522191A1 (en) * 1985-06-21 1987-01-15 Cassella Ag PHOTOSTABILIZATION OF SYDNONIMINES
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
JPH0819004B2 (en) * 1986-12-26 1996-02-28 日清製粉株式会社 Sustained-release pharmaceutical preparation
IT1204725B (en) * 1987-06-17 1989-03-10 Edmond Pharma Srl DIPYRIDAMOL INCLUSION COMPLEXES WITH CYCLODESTRINE
SE8904296D0 (en) * 1989-12-21 1989-12-21 Pharmacia Ab TRANSDERMAL SYSTEM
AU7574391A (en) * 1990-04-06 1991-10-30 Gerhard Blatt Installation for conditioning concrete blocks

Also Published As

Publication number Publication date
FI104882B (en) 2000-04-28
EP0478732B1 (en) 1998-09-09
HK1011688A1 (en) 1999-07-16
RO109336B1 (en) 1995-01-30
MD940334A (en) 1996-10-31
CA2054213A1 (en) 1991-09-29
DK0478732T3 (en) 1999-06-07
MD776C2 (en) 1998-05-31
BG61812B1 (en) 1998-06-30
ES2121780T3 (en) 1998-12-16
PL165866B1 (en) 1995-02-28
MW6891A1 (en) 1993-07-14
AU635835B2 (en) 1993-04-01
CN1055928A (en) 1991-11-06
FI915570A0 (en) 1991-11-26
EP0478732A1 (en) 1992-04-08
LV10087B (en) 1995-02-20
LT3257B (en) 1995-05-25
RU2107695C1 (en) 1998-03-27
DE69130146T2 (en) 1999-04-01
GEP19991743B (en) 1999-09-10
LV10087A (en) 1994-05-10
SI9110909A (en) 1998-06-30
WO1991014681A1 (en) 1991-10-03
UA27242C2 (en) 2000-08-15
ATE170849T1 (en) 1998-09-15
HU901869D0 (en) 1990-07-28
KR950004706B1 (en) 1995-05-04
PL293020A1 (en) 1992-12-28
MD776B2 (en) 1997-07-31
HRP920560A2 (en) 1994-04-30
HRP920560B1 (en) 1999-12-31
HU211648A9 (en) 1995-12-28
NO303634B1 (en) 1998-08-10
OA09522A (en) 1992-11-15
JP2549961B2 (en) 1996-10-30
CZ285695B6 (en) 1999-10-13
KR920701183A (en) 1992-08-11
JPH04506221A (en) 1992-10-29
CN1051081C (en) 2000-04-05
US5298496A (en) 1994-03-29
MC2186A1 (en) 1992-09-16
HU212730B (en) 1996-10-28
CA2054213C (en) 1998-12-01
DE69130146D1 (en) 1998-10-15
SI9110909B (en) 1999-02-28
HUT58110A (en) 1992-01-28
AU7549391A (en) 1991-10-21
NO914650D0 (en) 1991-11-27
NO914650L (en) 1991-11-27
CZ85291A3 (en) 1993-11-17
LTIP387A (en) 1994-09-25
BR9105137A (en) 1992-08-04

Similar Documents

Publication Publication Date Title
YU69991A (en) PYRIDINE DERIVATIVES
HUT47550A (en) Process for producing tetrazole derivatives
CS161892A3 (en) Heterocyclic derivatives, process of their preparation and pharmaceuticalcompositions in which said derivatives are comprised
IL136044A (en) 2-aminoacetamide derivatives and pharmaceutical compositions containing the same
IL98392A0 (en) Indole derivatives,their preparation and pharmaceutical compositions containing them
HUT75123A (en) 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazole derivatives
MX9503529A (en) Glycinamide derivatives, process for their preparation and medicaments containing them.
EP0531016A3 (en) Polysulfate of beta-cyclodextrin derivative and process for preparing the same
IL75115A0 (en) Beta-carboline-3-oxadiazolyl derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
TJ189R3 (en) Inclusion complexes of 3-morpholinesydnonimine or its salts, or its tautomeric isomer with cyclodextrine or its deri-vatives, method for preparation thereof, pharmaceutical composition thereof, methodfor preparation thereof and for treatment of sten ocardia or ishemic desease.
AU2401584A (en) Novel carbacyclins, process for their manufacture and their use as medicaments
DE3472791D1 (en) Gamma-butyrolactone derivatives, process for preparing the same and immunomodulating compositions containing the same as active ingredients
TW336235B (en) 3'-aziridino-anthracycline derivatives, process for preparating them and pharmaceutical composition containing them
ES8602705A1 (en) Triazine derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same.
HUT70480A (en) Mono and bis alkylamino-anthracyclines pharmaceutical compns. contg. them and process to prepare the said compds.
UA29395C2 (en) Derivative of pregna-4,9(11),17(20)-trien-3-on, a process for preparation thereof, a process for preparation of 21-acyloxypregna-4,9(11),16-trien-3,20-dion and intermediary compounds
ES8602761A1 (en) Pyrimidone derivatives.
UA41903C2 (en) process for obtaining substituted imidazole derivatives or pharmaceutically acceptable salts thereof
PT99146A (en) Process for the preparation of inclusion complexes with silibinine and pharmaceutical compositions containing them
AU1466592A (en) Gem-diphosphonic acid nitrosocarbamoyl derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
HUT39731A (en) Process for preparing arphamenine derivatives and pharmaceutical compositions containing such compounds
MY102682A (en) Substituted pyridinesulfonamide compounds, herbicidal composition containing them, and method of preparing these compounds